A precision medicine trial in psoriatic arthritis—first jump in the deep end

0
0 / 5 (0 votos)

Rheumatology Oxford Journal

Fecha de publicación: 2 june 2018

DOI: https://doi.org/10.1093/rheumatology/key160

Autores: Emmerik F A Leijten

Background: PsA is a disease with a wide array of clinical manifestations and a growing set of treatment options. In clinical practice, it is often required to try various biologics before the desired response is attained.

Seguir leyendo